Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 27Lymphoma 22Hematologic Diseases 20Lymphoma, Large-Cell, Anaplastic 16Lymphoma, Non-Hodgkin 11Recurrence 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 4Lymphoma, T-Cell, Cutaneous 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Melanoma 2Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphomatoid Papulosis 1

Interventions

dacetuzumab 7blinatumomab 6Rituximab 5ibrutinib 3Cyclophosphamide 3venetoclax 2tetulomab tetraxetan lu-177 2ponatinib 2fludarabine 2ferric carboxymaltose 2cobomarsen 2Vorinostat 2Valganciclovir 2Lutetium 2Lenalidomide 2Ifosfamide 2Ganciclovir 2Everolimus 2Dexamethasone 2Bortezomib 2ruxolitinib 1pomalidomide 1pegaspargase 1ficlatuzumab 1epratuzumab 1enzalutamide 1durvalumab 1denileukin diftitox 1cirmtuzumab 1asparaginase erwinia chrysanthemi recombinant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Lymphoproliferative Disorders × Brentuximab Vedotin × Clear all
NCT01990534 2021-04-09

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Takeda

Phase 4 Completed
60 enrolled 21 charts
Lymphoid

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡